Gerresheimer Stock - Analyst views and sector check into the weekend
Published on 06/19/2026 at 15:24 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 15:20 CET. Details in the imprint.
Gerresheimer (DE000A0LD6E6) sits at the intersection of pharmaceutical packaging and medical technology services for global drugmakers. With no fresh ad-hoc releases or major rating changes reported by leading wires or brokerages today, the end-of-week view centers on consensus expectations and the broader healthcare packaging sector.
All news and background on Gerresheimer stock
Key figures, news flow and regulatory filings on Gerresheimer are collected in the dedicated topic section and on the company’s Investor Relations page.
How analysts frame Gerresheimer
Recent broker commentary, as compiled on major financial portals, reflects a broadly constructive but selective stance on Gerresheimer, with many houses highlighting its exposure to injectable drugs, biologics and GLP-1 therapies as structural drivers for specialized packaging demand.
The consensus picture sketched on several data platforms points to expectations of moderate revenue growth paired with a gradual margin improvement over the next few years, underpinned by capacity expansions and a richer mix of solutions for pharma customers.
Position in the healthcare packaging sector
Against the wider backdrop, Gerresheimer competes with international peers in primary pharmaceutical packaging, medical devices components and drug delivery systems, a niche where switching costs and regulatory approvals can support relatively stable customer relationships.
For the week, many investors are comparing Gerresheimer’s valuation multiples with those of broader healthcare suppliers and device makers, assessing whether its mix of growth projects and recurring packaging business justifies a sector-level or modest premium rating.
How the company makes money
Gerresheimer primarily generates revenue by supplying primary packaging such as glass and plastic vials, syringes and containers, as well as complex drug delivery systems and medical plastic systems for pharmaceutical and biotechnology clients worldwide.
Where the stock trades today
The shares of Gerresheimer (DE000A0LD6E6) trade on Xetra at EUR 100.00 as of 06/19/2026, 15:20 CET.
Key facts on Gerresheimer stock
- Company: Gerresheimer AG
- ISIN: DE000A0LD6E6
- WKN: A0LD6E
- Ticker: GXI
- Venue: Xetra
- Price (as of 06/19/2026, 15:20 CET): 100.00 EUR
- Market cap: 3,200,000,000 EUR (as of 06/19/2026)
- Sector / Industry: Health Care - Medical Supplies & Pharmaceuticals Packaging
- Index membership: MDAX, Stoxx Europe 600
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
